Diabetes Reusable Insulin Pen Market to Surpass USD 3 Bn in 10MM by 2022, States DPI Research in Its New Report Available at MarketPublishers.com14 Jul 2017 • by Natalie Aster
LONDON – The market for diabetes reusable insulin pens is projected to surpass the USD 3 billion mark across the 10 major markets (10MM) by 2022. The market growth is mainly propelled by the expanding diabetes patient population, product’s increased adoption rate, ease of use helping to help avoid over/under–dosing of insulin, growing popularity amid consumers, rising demand for analogues of human insulin, government support and technology advances in the domain of reusable insulin pen devices.
China is anticipated to take the lead in the reusable insulin pen market, capturing over 50% of the market by 2022. Germany is the second largest market player and is anticipated to maintain its current position in the years to come. The USA is projected to rank third in the market by end-2022.
Eli Lilly, Novo Nordisk, Sanofi, Ypsomed, Owen Mumford, and Biocon Ltd, are among the top players in the marketplace.
New study “Global Diabetes Reusable Insulin Pen Market Report: Country Outlook, Analysis, Size, Share and Forecast 2017 – 2022” created by DPI Research & Marketing Solutions offers an in-depth, unbiased analysis of the marketplace globally, focusing on the USA, Germany, Italy, France, Spain, the UK, Japan, India, China, and Brazil.
The report canvasses the market demand, explores the competitive landscape and discusses the trends of the 10MM of the reusable insulin pen market. It provides an in–depth assessment of total diabetes population and insulin users. It provides true insights into reusable insulin pen market and users for the 10 leading countries through to 2022. The report also explores key market growth drivers and factors limiting the market growth. The research examines the dominant market players covering various parameters such as business overview, product outlook and most recent development and trends of the insulin pen marketplace.
All the 10MM are examined from 4 viewpoints, namely overall diabetes population; insulin users; reusable (cartridge) insulin pen users; and reusable (cartridge) insulin pen market.
More new comprehensive reports by DPI Research & Marketing Solutions can be found on the publisher’s page at MarketPublishers.com.